To explore the association between TLR-4 and p38 signaling in mediating thrombin-dependent endothelial inflammation, we employed pharmacological inhibitors of TLR-4 and p38, and then measured their effects on each other signaling pathway activation, respectively. Here, MAPK14 is linked to inflammatory response.